Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers
- PMID: 31984571
- PMCID: PMC7154637
- DOI: 10.1111/ctr.13790
Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers
Abstract
Background: Cell-free microRNAs (miRs) have emerged as early and sensitive biomarkers for tissue injury and function. This study aimed to investigate whether the release of hepatocyte-derived microRNAs (HDmiRs) and cholangiocyte-derived miRs (CDmiRs) correlates with hepato-cholangiocellular injury and function during oxygenated, normothermic machine perfusion (NMP) of human liver grafts.
Methods: Donor livers (n = 12), declined for transplantation, were subjected to oxygenated NMP (6 hours) after a period of static cold storage (median 544 minutes (IQR 421-674)). Perfusate and bile samples were analyzed by qRT-PCR for HDmiR-122 and CDmiR-222. Spearman correlations were performed between miR levels and currently available indicators and classic markers.
Results: Both HDmiR-122 and CDmiR-222 levels in perfusate at 30 minutes of NMP strongly correlated with hepatocyte injury (peak perfusate AST) and cholangiocyte injury (peak biliary LDH). In bile, only CDmiR-222 correlated with these injury markers. For hepato-cholangiocellular function, both miRs in perfusate correlated with total bilirubin, while HDmiR-122 (in perfusate) and CDmiR-222 (in bile) correlated with bicarbonate secretion. Both the relative ratio of HDmiR-122/CDmiR-222 and AST in perfusate at 30 minutes significantly correlated with cumulative bile production, but only the relative ratio was predictive of histopathological injury after 6 hours NMP.
Conclusion: Early levels of HDmiR-122 and CDmiR-222, in perfusate and/or bile, are predictive of excretory functions and hepato-cholangiocellular injury after 6 hours NMP. These miRs may represent new biomarkers for graft viability and function during machine perfusion.
Keywords: biomarker; cholangiocyte-derived microRNA; hepatocyte-derived microRNA; miR-122; miR-222; transplantation.
© 2020 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures





References
-
- Jochmans I, van Rosmalen M, Pirenne J, Samuel U. Adult liver allocation in eurotransplant. Transplantation. 2017;101(7):1542. - PubMed
-
- Barshes NR, Horwitz IB, Franzini L, Vierling JM, Goss JA. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant. 2007;7(5):1265. - PubMed
-
- Blok JJ, Detry O, Putter H, et al. Longterm results of liver transplantation from donation after circulatory death. Liver Transpl. 2016;22(8):1107. - PubMed
-
- de Vries Y, von Meijenfeldt FA, Porte RJ. Post‐transplant cholangiopathy: classification, pathogenesis, and preventive strategies. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4):1507‐1515. - PubMed
-
- Meurisse N, Vanden Bussche S, Jochmans I, et al. Outcomes of liver transplantations using donations after circulatory death: a single‐center experience. Transplant Proc. 2012;44(9):2868. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical